Maintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 30, 2016, Pages 8532-8537

  Yuan, Qi ^a,b   Yang, Jingyi ^a,b,c   Santulli, Gaetano ^a,b   Reiken, Steven R ^a,b   Wronska, Anetta ^a,b   Kim, Mindy M ^a   Osborne, Brent W ^a   Lacampagne, Alain ^d   Yin, Yuxin ^a,b   Marks, Andrew R ^a,b,e  

^a Department of Medicine   (United States)

^b Molecular Cardiology Program   (United States)

^c Neuroscience Research Institute   (China)

^d UNIV MONTPELLIER   (France)

^e Columbia University ^*  (United States)

Author keywords

Calcium; Endothelium; ENOS; Hypertension; IP3 receptor

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PHENYLEPHRINE; TRANSCRIPTION FACTOR NFAT; ACETYLCHOLINE; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOMEGALY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELEMETRY; VASODILATATION; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; TRANSGENIC MOUSE;

ACETYLCHOLINE; ANIMALS; BLOOD PRESSURE; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NITRIC OXIDE SYNTHASE TYPE III; VASODILATION; VASODILATOR AGENTS;

EID: 84979587331     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1608859113     Document Type: Article

References (47)

1. Santulli G (2013) Epidemiology of cardiovascular disease in the 21st century: Updated numbers and updated facts. J Cardiovasc Dis 1(1):1-2.
2. Blacher J, Levy BI, Mourad JJ, Safar ME, Bakris G (February 5, 2016) From epidemiological transition to modern cardiovascular epidemiology: Hypertension in the 21st century. Lancet, 10.1016/S0140-6736(16)00002-7.
3. Lackland DT, Weber MA (2015) Global burden of cardiovascular disease and stroke: Hypertension at the core. Can J Cardiol 31(5):569-571.
4. Santulli G, Trimarco B, Iaccarino G (2013) G-protein-coupled receptor kinase 2 and hypertension: Molecular insights and pathophysiological mechanisms. High Blood Press Cardiovasc Prev 20(1):5-12.
5. Hansson JH, et al. (1995) Hypertension caused by a truncated epithelial sodium channel gamma subunit: Genetic heterogeneity of Liddle syndrome. Nat Genet 11(1): 76-82.
6. Lanni F, et al. (2007) The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: Increased risk of ischemic stroke in high-risk patients. J Hypertens 25(3):551-556.
7. Coffman TM (2014) The inextricable role of the kidney in hypertension. J Clin Invest 124(6):2341-2347.
8. Lifton RP (1996) Molecular genetics of human blood pressure variation. Science 272(5262):676-680.
9. Iaccarino G, et al. (2004) AKT participates in endothelial dysfunction in hypertension. Circulation 109(21):2587-2593.
10. Koch-Weser J (1974) Vasodilator drugs in the treatment of hypertension. Arch Intern Med 133(6):1017-1027.
11. van Gelder T, van Schaik RH, Hesselink DA (2014) Pharmacogenetics and immunosuppressive drugs in solid organ transplantation. Nat Rev Nephrol 10(12):725-731.
12. Rodríguez-Perálvarez M, De la Mata M, Burroughs AK (2014) Liver transplantation: Immunosuppression and oncology. Curr Opin Organ Transplant 19(3):253-260.
13. Zbroch E, Małyszko J, Mysliwiec M, Przybyłowski P, Durlik M (2012) Hypertension in solid organ transplant recipients. Ann Transplant 17(1):100-107.
14. Palmer RM, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L- Arginine. Nature 333(6174):664-666.
15. Rapoport RM, Draznin MB, Murad F (1983) Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 306(5939):174-176.
16. Luksha L, Agewall S, Kublickiene K (2009) Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis 202(2):330-344.
17. Santulli G, et al. (2012) CaMK4 gene deletion induces hypertension. J Am Heart Assoc 1(4):e001081.
18. Chataigneau T, et al. (1999) Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol 126(1):219-226.
19. Matoba T, et al. (2000) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106(12):1521-1530.
20. Shesely EG, et al. (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93(23):13176-13181.
21. Taylor MS, Francis M (2014) Decoding dynamic Ca(2+) signaling in the vascular endothelium. Front Physiol 5:447.
22. Kochukov MY, Balasubramanian A, Abramowitz J, Birnbaumer L, Marrelli SP (2014) Activation of endothelial transient receptor potential C3 channel is required for small conductance calcium- Activated potassium channel activation and sustained endothelial hyperpolarization and vasodilation of cerebral artery. J Am Heart Assoc 3(4):e000913.
23. Santulli G, Marks AR (2015) Essential roles of intracellular calcium release channels in muscle, brain, metabolism, and aging. Curr Mol Pharmacol 8(2):206-222.
24. Yang J, et al. (2002) Identification of a family of calcium sensors as protein ligands of inositol trisphosphate receptor Ca(2+) release channels. Proc Natl Acad Sci USA 99(11):7711-7716.
25. Marques FZ, Campain AE, Yang YH, Morris BJ (2010) Meta- Analysis of genome-wide gene expression differences in onset and maintenance phases of genetic hypertension. Hypertension 56(2):319-324.
26. Edwards JS, et al. (2014) Integrated statistical and pathway approach to next-generation sequencing analysis: A family-based study of hypertension. BMC Proc 8(Suppl 1):S104.
27. Graef IA, Chen F, Chen L, Kuo A, Crabtree GR (2001) Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 105(7):863-875.
28. Rinne A, Banach K, Blatter LA (2009) Regulation of nuclear factor of activated T cells (NFAT) in vascular endothelial cells. J Mol Cell Cardiol 47(3):400-410.
29. Zetterqvist AV, et al. (2015) Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic mice. J Diabetes Res 2015:428473.
30. Gurley SB, et al. (2011) AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 13(4):469-475.
31. Crowley SD, Gurley SB, Coffman TM (2007) AT(1) receptors and control of blood pressure: The kidney and more.... Trends Cardiovasc Med 17(1):30-34.
32. Ciccarelli M, et al. (2014) CaMKII protects MKP-1 from proteasome degradation in endothelial cells. Cell Signal 26(10):2167-2174.
33. Rafikov R, et al. (2011) eNOS activation and NO function: Structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. J Endocrinol 210(3):271-284.
34. Nguyen H, et al. (2013) Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc Res 97(4):696-704.
35. Ritter O, et al. (2003) AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway. FASEB J 17(2):283-285.
36. Adams DJ, Barakeh J, Laskey R, Van Breemen C (1989) Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 3(12):2389-2400.
37. Kou R, Greif D, Michel T (2002) Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem 277(33):29669-29673.
38. Cárdenas C, et al. (2010) Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 142(2):270-283.
39. Santulli G, Xie W, Reiken SR, Marks AR (2015) Mitochondrial calcium overload is a key determinant in heart failure. Proc Natl Acad Sci USA 112(36):11389-11394.
40. Santulli G, et al. (2014) A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J Clin Invest 124(9):4102-4114.
41. Santulli G, et al. (2009) In vivo properties of the proangiogenic peptide QK. J Transl Med 7:41.
42. Xie W, et al. (2013) Imaging atrial arrhythmic intracellular calcium in intact heart. J Mol Cell Cardiol 64:120-123.
43. Santulli G, et al. (2015) Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J Clin Invest 125(5):1968-1978.
44. Yuan Q, et al. (2014) Functional role of Calstabin2 in age-related cardiac alterations. Sci Rep 4:7425.
45. Umanskaya A, et al. (2014) Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging. Proc Natl Acad Sci USA 111(42):15250-15255.
46. Xie W, et al. (2015) Mitochondrial oxidative stress promotes atrial fibrillation. Sci Rep 5:11427.
47. Santulli G, et al. (2012) Age-related impairment in insulin release: The essential role of β(2)- Adrenergic receptor. Diabetes 61(3):692-701.